7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Application of nitric oxide in drug discovery and development

      Expert Opinion on Drug Discovery
      Informa Healthcare

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references97

          • Record: found
          • Abstract: not found
          • Article: not found

          Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide.

            Nitric oxide was found to trigger mitochondrial biogenesis in cells as diverse as brown adipocytes and 3T3-L1, U937, and HeLa cells. This effect of nitric oxide was dependent on guanosine 3',5'-monophosphate (cGMP) and was mediated by the induction of peroxisome proliferator-activated receptor gamma coactivator 1alpha, a master regulator of mitochondrial biogenesis. Moreover, the mitochondrial biogenesis induced by exposure to cold was markedly reduced in brown adipose tissue of endothelial nitric oxide synthase null-mutant (eNOS-/-) mice, which had a reduced metabolic rate and accelerated weight gain as compared to wild-type mice. Thus, a nitric oxide-cGMP-dependent pathway controls mitochondrial biogenesis and body energy balance.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Reducing implant-related infections: active release strategies.

              Despite sterilization and aseptic procedures, bacterial infection remains a major impediment to the utility of medical implants including catheters, artificial prosthetics, and subcutaneous sensors. Indwelling devices are responsible for over half of all nosocomial infections, with an estimate of 1 million cases per year (2004) in the United States alone. Device-associated infections are the result of bacterial adhesion and subsequent biofilm formation at the implantation site. Although useful for relieving associated systemic infections, conventional antibiotic therapies remain ineffective against biofilms. Unfortunately, the lack of a suitable treatment often leaves extraction of the contaminated device as the only viable option for eliminating the biofilm. Much research has focused on developing polymers that resist bacterial adhesion for use as medical device coatings. This tutorial review focuses on coatings that release antimicrobial agents (i.e., active release strategies) for reducing the incidence of implant-associated infection. Following a brief introduction to bacteria, biofilms, and infection, the development and study of coatings that slowly release antimicrobial agents such as antibiotics, silver ions, antibodies, and nitric oxide are covered. The success and limitations of these strategies are highlighted.
                Bookmark

                Author and article information

                Journal
                Expert Opinion on Drug Discovery
                Expert Opinion on Drug Discovery
                Informa Healthcare
                1746-0441
                1746-045X
                October 25 2011
                November 2011
                August 25 2011
                November 2011
                : 6
                : 11
                : 1139-1154
                Article
                10.1517/17460441.2011.613933
                6f518c3a-ee72-4d71-a5e8-c0341654645a
                © 2011
                History

                Comments

                Comment on this article